Harmony Biosciences Holdings's market cap is currently $1.99B. The company's EPS TTM is $2.112; its P/E ratio is 16.52; Harmony Biosciences Holdings is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $0.73. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 582.02M	$ 437.86M	$ 305.44M	$ 159.74M	$ 6.00M
Gross Profit	$ 460.79M	$ 354.37M	$ 249.92M	$ 132.00M	$ 4.42M
Operating Income	$ 192.03M	$ 120.19M	$ 68.70M	$ 3.68M	$ -145.90M
EBITDA	$ 221.51M	$ 143.57M	$ 106.37M	$ 1.51M	$ -142.69M
Net Income	$ 128.85M	$ 181.47M	$ 34.60M	$ -51.86M	$ -158.05M
Balance Sheet
Cash & Short-Term Investments	$ 353.46M	$ 323.12M	$ 234.31M	$ 228.63M	$ 24.46M
Total Assets	$ 811.45M	$ 673.87M	$ 433.44M	$ 427.07M	$ 106.70M
Total Debt	$ 193.57M	$ 191.65M	$ 191.98M	$ 194.25M	$ 97.95M
Net Debt	$ -118.09M	$ -52.14M	$ -42.33M	$ -34.38M	$ 73.49M
Total Liabilities	$ 344.46M	$ 271.03M	$ 246.94M	$ 329.89M	$ 118.29M
Stockholders' Equity	$ 466.99M	$ 402.84M	$ 186.51M	$ 97.18M	$ -11.59M
Cash Flow
Free Cash Flow	$ 219.07M	$ 104.29M	$ -1.74M	$ -4.99M	$ -202.59M
Operating Cash Flow	$ 219.39M	$ 144.47M	$ 98.56M	$ -2.98M	$ -75.44M
Investing Cash Flow	$ -46.44M	$ -141.83M	$ -100.30M	$ -2.00M	$ -127.15M
Financing Cash Flow	$ -105.55M	$ 6.84M	$ 7.42M	$ 209.16M	$ 143.77M

Currency in USD

Harmony Biosciences Holdings Earnings and Revenue History

Income Statement >

Harmony Biosciences Holdings Debt to Assets

Balance Sheet >

Harmony Biosciences Holdings Cash Flow

Cash Flow >

Harmony Biosciences Holdings Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing